Related Experiment Video
Updated: Jul 4, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
Published on: September 30, 2025
Lipoprotein-associated phospholipase A2: a risk marker or a risk factor?
Amir Lerman1, Joseph P McConnell
1Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. lerman.amir@mayo.edu
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is a unique biomarker for cardiovascular disease (CVD) risk. It specifically indicates plaque inflammation and remains a significant predictor even when accounting for traditional risk factors.
Area of Science:
- Cardiology
- Biochemistry
- Vascular Biology
Background:
- Cardiovascular disease (CVD) risk is influenced by multiple biomarkers.
- Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is implicated in the inflammatory processes of atherosclerotic plaques.
Purpose of the Study:
- To review the clinical utility of Lp-PLA(2).
- To evaluate Lp-PLA(2) as both a cardiovascular risk marker and a causal factor in plaque inflammation and rupture.
Main Methods:
- Review of existing studies on Lp-PLA(2) in primary and secondary prevention populations.
- Analysis of Lp-PLA(2) association with cardiovascular risk, considering both mass concentration and enzyme activity.
- Assessment of the impact of conventional CVD risk factors on Lp-PLA(2) risk estimates.
Main Results:
- Lp-PLA(2) is consistently associated with increased cardiovascular risk across different populations.
- This association remains significant even after adjusting for conventional CVD risk factors.
- Risk estimates were comparable whether Lp-PLA(2) mass or activity was measured.
Conclusions:
- Lp-PLA(2) demonstrates significant clinical utility as a biomarker for cardiovascular risk.
- Lp-PLA(2) plays a role in the causal pathway of plaque inflammation, contributing to rupture-prone plaque formation.
- Its unique specificity for plaque inflammation makes it a valuable addition to CVD risk assessment.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis I: Introduction
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Peripheral Artery Disease I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...